By Vaishali Nambiar The interconnection of healthcare with IT has gotten deeper than one could have ever imagined. In 2022, the global healthcare IT market size was valued at $ 174.3 billion, with an expected CAGR of 18.2 per cent from 2023 to 2030, reaching $ 644.9 billion by 2030 In the realm of healthcare, … Read more
Waltham: In order to drive scientific collaboration across R&D disciplines from drug discovery to specialty chemicals material development, Revvity, Inc. today announced the launch of its Signals Research Suite, a unified, cloud-native SaaS platform. The new solution from Revvity Signals Software, the software and informatics arm of Revvity, will be available worldwide. The SaaS platform … Read more
Waltham: In order to drive scientific collaboration across R&D disciplines from drug discovery to specialty chemicals material development, Revvity, Inc. today announced the launch of its Signals Research Suite, a unified, cloud-native SaaS platform. The new solution from Revvity Signals Software, the software and informatics arm of Revvity, will be available worldwide. The SaaS platform … Read more
By Raj Srinivasaraghavan The cloud is enveloping more sectors, faster and deeper. Health and pharmaceuticals are exception. Rather, the two sectors have been one of the pioneers to adopt cloud and other futuristic technologies. More than being an enabler, cloud has now emerged as an inevitable technology for the sector as a whole and new … Read more
By Nilesh Jahagirdar Artificial Intelligence (AI) has been prevalent in almost every business sector. However, in recent years, technology has burst into the healthcare landscape, propelling innovations and showcasing the potential to support medical practitioners and patients. From early disease diagnosis, drug discovery and trials, and precision in patient monitoring to self-care, AI algorithms have … Read more
By Dr Mahesh Bhalgat Artificial intelligence (AI) presents the possibility to alter the drug discovery process and has grown significantly, in the past few years. Over 150 companies have applied AI-based drug discovery approaches to raise funds and progress molecules into clinical trials. Before diving into the use of Artificial Intelligence in drug discovery, a … Read more